CD4 and acute myeloid leukemia: The results demonstrated that in the cohorts under age 60, the frequency of TIGIT on the CD4+ T cells of DN AML patients was higher than that on HIs (26.31% vs 20.14%, p=0.038); however, there was no difference in other comparisons between AML and HIs in the same age cohorts (Supplementary Figure 1).